Bypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models.
<h4>Background</h4>Prostate cancer is initially dependent on androgens for survival and growth, making hormonal therapy the cornerstone treatment for late-stage tumors. However, despite initial remission, the cancer will inevitably recur. The present study was designed to investigate how...
Guardado en:
Autores principales: | Rute B Marques, Natasja F Dits, Sigrun Erkens-Schulze, Wytske M van Weerden, Guido Jenster |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/23e2616e34464feaac35cb0715fc130a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines.
por: Rute B Marques, et al.
Publicado: (2011) -
Modeling Prostate Cancer Treatment Responses in the Organoid Era: 3D Environment Impacts Drug Testing
por: Annelies Van Hemelryk, et al.
Publicado: (2021) -
Novel lipid mediators contributing to androgen receptor therapy resistance in prostate cancer
por: Sreenivasa R. Chinni
Publicado: (2021) -
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
por: Mohammad Asim, et al.
Publicado: (2017) -
Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
por: Aasems Jacob, et al.
Publicado: (2021)